Treatment Options in Alzheimer’s Disease: Maximizing Benefit, Managing Expectations

Alzheimer’s disease (AD) is becoming an increasingly heavy burden on the society of developed countries, and physicians now face the challenge of providing efficient treatment regimens to an ever-higher number of individuals affected by the disease. Currently approved anti-AD therapies – the cholinesterase inhibitors and the N-methyl-<i>D</i>-aspartate receptor antagonist memantine – offer modest symptomatic relief, which can be...